title: Encapsulating peritoneal sclerosis in a peritoneal dialysis patient presenting with complicated Mycobacterium fortuitum peritonitis.
abstract: Encapsulating peritoneal sclerosis (EPS) is a rare but serious complication seen in patients undergoing continuous ambulatory peritoneal dialysis (CAPD) or automated peritoneal dialysisAPD after prolonged duration on dialysis. Patients usally present with vague complaints of abdominal pain, vomitting, diarrhea, weight loss and change in peritoneal transport characte-ristics. High degree of suspicion is needed in PD patients who have been on dialysis for prolonged duration and have been using high-concentrated dialysis fluid. Mycobacterium fortuitum (MF) is a rapidly growing, non-tuberculous mycobacterium that has rarely been reported as a pathogen causing peritonits in patients on PD. We report a case of CAPD presenting with culture-negative peritonits, which, on specific culture, grew MF and, on radiological evaluation, showed diagnostic features of EPS.
authors.affiliation: Division of Nephrology, Department of Medicine, King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia. mohdamin1126@yahoo.com
authors.forename: Mohammed Amin
authors.initials: MA
authors.lastname: Simbli
authors.forename: Faraz A
authors.initials: FA
authors.lastname: Niaz
authors.forename: Jamal S
authors.initials: JS
authors.lastname: Al-Wakeel
mesh_terms: D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003928:Diabetic Nephropathies / Q000209:etiology / Q000628:therapy*; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000209:etiology / Q000628:therapy*; D008107:Liver Diseases / Q000209:etiology; D009102:Multiple Organ Failure / Q000209:etiology; D009165:Mycobacterium Infections, Nontuberculous / Q000175:diagnosis / Q000209:etiology* / Q000382:microbiology / Q000628:therapy; D019907:Mycobacterium fortuitum / Q000302:isolation & purification*; D010289:Parenteral Nutrition, Total; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects*; D056627:Peritoneal Fibrosis / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D010538:Peritonitis / Q000175:diagnosis / Q000209:etiology* / Q000382:microbiology / Q000628:therapy; D006435:Renal Dialysis; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents